<DOC>
	<DOC>NCT01540734</DOC>
	<brief_summary>A single dose pharmacokinetic study investigating two paracetamol formulations</brief_summary>
	<brief_title>Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With PanadolÂ®</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Good general heatlh with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or physical examination Subject does not agree to refrain from alcohol consumption for the 10day period prior to visit 2 and throughout the remainder of the study. Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit. Current (within 14 days of screening) or regular use of any prescription, over the counter drugs including paracetamol/acetaminophen, herbal medicine or drug known to induce or inhibit hepatic drug metabolism in the 30 days prior to dosing.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>paracetamol</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>